GlassScriptPhysician profile
Rahul Banerjee
NPI 1124095799
$5,159.25
in general payments reported to CMS, 2019-2025
28 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,726 · 2020: $204 · 2021: $380 · 2022: $973 · 2023: $700 · 2024: $735 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,877.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,836.61 | 2019-2025 | Axsos, Variax, Gamma |
| Abbott Laboratories | $942.75 | 2022-2025 | Eterna, Penta |
| Nuvasive Specialized Orthopedics, INC. | $444.01 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Medtronic, INC. | $322.22 | 2021-2025 | Aquamantys(Tm) |
| Smith+Nephew, INC. | $194.21 | 2019-2021 | |
| Depuy Synthes Sales INC. | $160.06 | 2021-2025 | Monovisc, Na, Orthovisc |
| Cumberland Pharmaceuticals, INC. | $152.50 | 2021-2023 | Caldolor |
| Cerapedics INC. | $140.84 | 2022 | |
| Bioventus LLC | $117.73 | 2023-2025 | Exogen Ultrasound Bone Healing System, Durolane, Durolane |
| Janssen Biotech, INC. | $105.80 | 2024 | Darzalex, Talvey, Tecvayli |
| Zimmer Biomet Holdings, INC. | $97.30 | 2020-2024 | Persona, Arcos, Taperloc |
| Orthofix Medical, INC. | $79.02 | 2025 | Cervical-Stim, Physio-Stim |
| Globus Medical, INC. | $74.96 | 2023-2024 | Proximal Tibia Plate, A/R Femoral Nail |
| Si-Bone, INC. | $70.49 | 2021 | |
| Cardiovascular Systems INC. | $64.13 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vision Quest Industries INC. | $58.07 | 2022 | |
| Pylant Medical | $47.42 | 2024 | |
| Innovation Technologies INC | $35.85 | 2023 | Irrisept |
| Xtant Medical INC | $35.03 | 2023 | |
| Next Science LLC | $30.95 | 2019 | |
| Biocomposites INC | $24.76 | 2019 | |
| Davol INC. | $23.65 | 2022 | |
| Surgalign Spine Technologies, INC. | $18.44 | 2022 | |
| Endo Pharmaceuticals INC. | $18.30 | 2021 | |
| Avanos Medical | $17.91 | 2022 | |
| Heron Therapeutics, INC. | $17.35 | 2021 | |
| Ossur Americas, INC. | $16.44 | 2024 | |
| Arteriocyte Medical Systems, INC. | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Banerjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.